Sublingual monomeric allergoid immunotherapy improves airway inflammation, airway hyperresponsiveness and clinical symptoms in allergic rhinitis and asthma

F. Romano, M. I. Scarlato, A. Mancuso, G. Bruni (Cosenza, Italy)

Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma
Session: Established and experimental therapies for allergic asthma
Session type: Thematic Poster Session
Number: 2559
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Romano, M. I. Scarlato, A. Mancuso, G. Bruni (Cosenza, Italy). Sublingual monomeric allergoid immunotherapy improves airway inflammation, airway hyperresponsiveness and clinical symptoms in allergic rhinitis and asthma. Eur Respir J 2006; 28: Suppl. 50, 2559

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lower airway inflammation and hyperresponsiveness in allergic and non-allergic rhinitis
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011


Upper and lower airway inflammation and bronchial hyperresponsiveness in allergic rhinitis children with or without asthma
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011

Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019




Potential reduction of bronchial hyperreactivity under allergic rhinitis
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009

Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

Effect of desloratadine on patients suffer from allergic rhinitis and bronchial hyperreactivity
Source: Eur Respir J 2003; 22: Suppl. 45, 135s
Year: 2003

Specific allergen immunotherapy of asthma combined with allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

Small airways dysfunction: the link between allergic rhinitis and allergic asthma
Source: Eur Respir J, 51 (2) 1701749; 10.1183/13993003.01749-2017
Year: 2018



Studies of bronchial hyperreactivity in pediatric patients with allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 391s
Year: 2002

Evaluation bronchial hyperresponsivness in patients with persistent allergic rhinitis
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018


The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Bronchial hyperresponsiveness and perception of dyspnea in children with allergic rhinitis and bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 441s
Year: 2004

Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001

Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 104s
Year: 2003

Effect of nasal allergen challenge on non-invasive markers of inflammation in allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 592s
Year: 2006

Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008


Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


The nose–lung interaction in allergic rhinitis and asthma: united airways disease
Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside
Year: 2007